This trial will test a lifestyle intervention including diet and exercise, enhanced by self-monitoring health technologies, on weight and diabetes outcomes and diabetic complications in 60 overweight/obese adults with or without T2D. Renal function will be assessed using traditional and novel biomarkers, including novel metabolites and mitochondrial function.
5 Primary · 1 Secondary · Reporting Duration: Baseline to 6 months
60 Total Participants · 2 Treatment Groups
Primary Treatment: mHealth + low-carb/ketogenic diet · Has Placebo Group · N/A
Age 18+ · All Participants · 9 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
|18 - 65||50.0%|
|UT Health San Antonio School of Nursing||100.0%|
|Did not meet criteria||12.5%|